907 results on '"Thaker, Premal H"'
Search Results
102. Feeling powerless: Locus of control as a potential target for supportive care interventions to increase quality of life and decrease anxiety in ovarian cancer patients
103. A phase I study of IV doxorubicin plus intraperitoneal (IP) paclitaxel and IV or IP cisplatin in endometrial cancer patients at high risk for peritoneal failure (GOG 9920): An NRG Oncology/Gynecologic Oncology Group study
104. A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study
105. Awareness of the association between obesity and peri-operative risk among newly diagnosed patients with complex atypical hyperplasia and endometrial cancer
106. Impact of an immunohistochemistry-based universal screening protocol for Lynch syndrome in endometrial cancer on genetic counseling and testing
107. Nothing left to chance? The impact of locus of control on physical and mental quality of life in terminal cancer patients
108. Endometrial Cancer Surveillance Counterpoint: USA
109. Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib + bevacizumab first-line maintenance therapy in the COMB1NE study.
110. High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer
111. Biobehavioral factors predict an exosome biomarker of ovarian carcinoma disease progression
112. Assessment of quality improvement priorities to improve care delivery for patients with ovarian cancer.
113. A phase II trial of a surgical protocol to decrease the incidence of wound complications in obese gynecologic oncology patients
114. A phase II evaluation of pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group study
115. Changes in spiritual well‐being and psychological outcomes in ovarian cancer survivors
116. Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma
117. Borderline Tumors of the Ovary
118. Genetic characterization of primary and metastatic high-grade serous ovarian cancer tumors reveals distinct features associated with survival.
119. NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022
120. Real-world utilization and outcomes of systemic therapy among patients with advanced or recurrent endometrial cancer in the United States
121. Management and prognosis of cervical cancer patients treated with definitive radiation therapy who have partial metabolic response on post-therapy positron emission tomography
122. Phase II study of bevacizumab and pemetrexed for recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal cancer
123. Non-cancer life stressors contribute to impaired quality of life in ovarian cancer patients
124. Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer
125. Intestinal perforation in gynecologic oncology: Do all patients benefit from surgical management?
126. Low yield of residual vulvar carcinoma and dysplasia upon re-excision for close or positive margins
127. Cortisol and inflammatory processes in ovarian cancer patients following primary treatment: Relationships with depression, fatigue, and disability
128. Wound Complication Rates After Staples or Suture for Midline Vertical Skin Closure in Obese Women: A Randomized Controlled Trial
129. Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence
130. Reply
131. A phase I study with an expanded cohort to assess feasibility of intravenous docetaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with previously untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study
132. Targeting those with decreased meaning and peace: a supportive care opportunity
133. Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer
134. Abstract 2429: Tumor and stromal AXL expression regulate ovarian cancer metastasis
135. Abstract 1025: Phase Ib trial single-arm efficacy estimates via comparison to a historical clinical trial synthetic control arm
136. Genomic analysis of clear cell carcinoma.
137. Real-world trends of PARPi maintenance treatment uptake and progression-free survival (PFS) in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) in the United States.
138. HER2 in uterine carcinosarcoma: Testing platforms and implications for targeted therapy.
139. Exploring the nuances between BRCA1 and 2: A multiomic analysis.
140. HER2 in endometrioid endometrial adenocarcinoma (E-EMCA): Defining incidence, molecular profiles, and outcomes.
141. GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis
142. 27 - Molecular oncology in gynecologic cancer: Immunologic Response, Cytokines, Oncogenes, and Tumor Suppressor Genes
143. Work related stress among gynecologic oncologists
144. Wound complications after gynecologic cancer surgery
145. GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress
146. Reply to beta blockers in epithelial ovarian cancer and beta-blockers and improved survival from ovarian cancer: New miracle treatment or another case of immortal person-time bias?
147. A case of ovarian cancer metastases causing a symptomatic paraesophageal hernia
148. Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer
149. Improving the quality of care for patients with advanced epithelial ovarian cancer: Program components, implementation barriers, and recommendations
150. Phase 1b study of AVB-500 in combination with paclitaxel or pegylated liposomal doxorubicin platinum-resistant recurrent ovarian cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.